1. Home
  2. GLDG vs ORGO Comparison

GLDG vs ORGO Comparison

Compare GLDG & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoldMining Inc.

GLDG

GoldMining Inc.

BUY

Current Price

$0.88

Market Cap

219.1M

ML Signal

BUY

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$1.26

Market Cap

181.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLDG
ORGO
Founded
2009
1985
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
219.1M
181.4M
IPO Year
2012
2016

Fundamental Metrics

Financial Performance
Metric
GLDG
ORGO
Price
$0.88
$1.26
Analyst Decision
Strong Buy
Hold
Analyst Count
4
2
Target Price
★ $3.09
$2.00
AVG Volume (30 Days)
494.2K
★ 591.0K
Earning Date
07-14-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1600.00
EPS
★ N/A
N/A
Revenue
N/A
★ $564,169,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$37.55
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 17.04
52 Week Low
$0.80
$1.28
52 Week High
$2.27
$7.08

Technical Indicators

Market Signals
Indicator
GLDG
ORGO
Relative Strength Index (RSI) 30.20 29.79
Support Level $0.86 N/A
Resistance Level $0.90 $2.69
Average True Range (ATR) 0.04 0.06
MACD -0.01 0.01
Stochastic Oscillator 7.95 2.04

Price Performance

Historical Comparison
GLDG
ORGO

About GLDG GoldMining Inc.

GoldMining Inc is a mineral exploration company with a focus on the acquisition, exploration, and development of projects in Colombia, Brazil, the United States, Canada, and Peru. Its principal projects are the La Mina Gold project and its Titiribi Gold-Copper project, located in Colombia; the Sao Jorge Gold Project, located in Brazil; and its interest in the Whistler Gold-Copper Project, located in Alaska, United States. Additionally, the company has several other projects in its portfolio, such as the Yellowknife Gold Project, Cachoeira Gold Project, Surubim Gold Project, Yarumalito Gold Project, Rea Uranium Project, etc. The firm has two operating segments, with U.S. GoldMining as one distinct operating segment and all other subsidiaries, or Others, being the second operating segment.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: